The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 28, 2019
Filed:
Mar. 16, 2009
Applicants:
Richard Schiff, Santa Rosa Valley, CA (US);
Heinz Leibl, Vienna, AT;
Inventors:
Richard Schiff, Santa Rosa Valley, CA (US);
Heinz Leibl, Vienna, AT;
Assignees:
Baxalta GmbH, Zug, CH;
Baxalta Incorporated, Bannockburn, IL (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/06 (2006.01); A61K 39/395 (2006.01); C12N 9/26 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/06 (2013.01); A61K 39/39516 (2013.01); C12N 9/2408 (2013.01); A61K 38/00 (2013.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); C07K 2317/21 (2013.01); Y02A 50/466 (2018.01);
Abstract
Provided are combinations, compositions and kits containing a immune globulin (IG) composition and a soluble hyaluronidase composition formulated for subcutaneous administration. Such products can be used in methods of treating IG-treatable diseases or conditions. Also provided are methods for subcutaneous administration of immune globulin whereby the dosing regimen is substantially the same as for intravenous administration of the same dosage for treatment of the same IG-treatable disease or condition.